PepGen Inc.
Develops oligonucleotide therapeutics for neuromuscular and neurological diseases.
PEPG | US
Overview
Corporate Details
- ISIN(s):
- US7133171055
- LEI:
- Country:
- United States of America
- Address:
- 1 MARINA PARK DRIVE, SUITE 900, 2210 BOSTON
- Website:
- https://pepgen.com
Description
PepGen Inc. is a clinical-stage biotechnology company focused on developing the next generation of oligonucleotide therapeutics. The company's proprietary Enhanced Delivery Oligonucleotide (EDO) technology is designed to safely and effectively deliver drug candidates to target the root cause of severe neuromuscular and neurological diseases. PepGen is advancing a pipeline of disease-modifying therapies with the goal of transforming treatment for patients with debilitating genetic disorders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PepGen Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PepGen Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PepGen Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
